A Single-center Experience With >200 Lung Transplant Recipients With COVID-19 Infection.

Hiromu KeharaAshley Johnson-WhitingRoh YanagidaKewal KrishanHuaqing ZhaoAaron MishkinFrancis CordovaGerard J CrinerYoshiya ToyodaNorihisa Shigemura

Published in: Transplantation direct (2024)

Overall survival after COVID-19 infection in lung transplant recipients continues to improve; however, in-hospital mortality remains remarkably high. Vaccination appears to have been impactful in preventing hospital admission, but its impact on in-hospital mortality is still unclear. Further research is needed to better identify lung transplant recipients at high risk for mortality from COVID-19.

Keyphrases

coronavirus disease
sars cov
cardiovascular disease
respiratory syndrome coronavirus
adverse drug
electronic health record